A metal processor covered here would appear to justify a much higher rating, while cash flow concerns continue to cast a shadow over a once popular litigation funder. Read on here for more on these and other stories.
The news that Pfizer and Germany’s BioNTech have made progress with a Covid-19 vaccine saw stock markets soar, although not all stocks rose, with some beneficiaries of the pandemic, notably small UK biotech stocks, falling sharply, as many clearly think their glory days will soon be coming to an end.
This seems somewhat premature to us, with plenty of work ahead before the vaccine becomes available to everyone and many biotech companies still likely to be…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on James Cropper
10/12/2024 · Company Insights
News covered here includes our assessment of results from one of AIM’s insolvency specialists. We consider…
20/11/2024 · Company Insights
Don’t be fooled by the 175 year history, this elderly business has a reputation for innovation…
More on Jubilee Metals Group
22/02/2021 · Company Insights
Are we on the verge of a new commodity supercycle, including gold and silver copper and…
10/11/2020 · Company Insights
A metal processor covered here would appear to justify a much higher rating, while cash flow…
More on Manolete Partners
23/11/2024 · Podcasts
In this episode of the Investors Champion Podcast, hosts Chris and Lee dive into the controversial…
20/11/2024 · Company Insights
A software provider whose results we assess here continues to recover from the consequences of a…
More on Zoo Digital
12/11/2024 · Company Insights
We cover yet another takeover of a fast-growing AIM company, this time at a big premium to…
26/03/2024 · Company Insights
Results and updates covered here include impressive news from two of our Bonkers Bargain opportunities, one…
More Company Insights
A struggling retailer issues a big profit warning
Another positive trading update but valuation remains modest
A corporate undertaker is reluctant to provide key information
More on James Cropper
More on Jubilee Metals Group
More on Manolete Partners
More on Zoo Digital
More Company Insights